MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia
- PMID: 33611795
- DOI: 10.1002/gcc.22943
MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia
Abstract
We investigated MYB rearrangements (MYB-R) and the levels of MYB expression, in 331 pediatric and adult patients with T-cell acute lymphoblastic leukemia (T-ALL). MYB-R were detected in 17 cases and consisted of MYB tandem duplication (tdup) (= 14) or T cell receptor beta locus (TRB)-MYB (= 3). As previously reported, TRB-MYB was found only in children (1.6%) while MYB tdup occurred in both age groups, although it was slightly more frequent in children (5.2% vs 2.8%). Shared features of MYB-R T-ALL were a non-early T-cell precursor (ETP) phenotype, a high incidence of NOTCH1/FBXW7 mutations (81%) and CDKN2AB deletions (70.5%). Moreover, they mainly belonged to HOXA (=8), NKX2-1/2-2/TLX1 (=4), and TLX3 (=3) homeobox-related subgroups. Overall, MYB-R cases had significantly higher levels of MYB expression than MYB wild type (MYB-wt) cases, although high levels of MYB were detected in ~ 30% of MYB-wt T-ALL. Consistent with the transcriptional regulatory networks, cases with high MYB expression were significantly enriched within the TAL/LMO subgroup (P = .017). Interestingly, analysis of paired diagnosis/remission samples demonstrated that a high MYB expression was restricted to the leukemic clone. Our study has indicated that different mechanisms underlie MYB deregulation in 30%-40% of T-ALL and highlighted that, MYB has potential as predictive/prognostic marker and/or target for tailored therapy.
Keywords: MYB expression; MYB tandem duplication; T-ALL; T-cell acute lymphoblastic leukemia; TRB-MYB.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Liu X, Xu Y, Han L, Yi Y. Reassessing the potential of Myb-targeted anti-cancer therapy. J Cancer. 2018;9(7):1259-1266. https://doi.org/10.7150/jca.23992.
-
- Pattabiraman DR, Gonda TJ. Role and potential for therapeutic targeting of MYB in leukemia. Leukemia. 2013;27(2):269-277. https://doi.org/10.1038/leu.2012.225.
-
- Ramsay RG, Gonda TJ. MYB function in normal and cancer cells. Nat Rev Cancer. 2008;8(7):523-534. https://doi.org/10.1038/nrc2439.
-
- Thomas MD, Kremer CS, Ravichandran KS, Rajewsky K, Bender TP. C-Myb is critical for B cell development and maintenance of follicular B cells. Immunity. 2005;23(3):275-286. https://doi.org/10.1016/j.immuni.2005.08.005.
-
- Nakano K, Uchimaru K, Utsunomiya A, Yamaguchi K, Watanabe T. Dysregulation of c-Myb pathway by aberrant expression of proto-oncogene MYB provides the basis for malignancy in adult T-cell leukemia/lymphoma cells. Clin Cancer Res. 2016;22(23):5915-5928. https://doi.org/10.1158/1078-0432.CCR-15-1739.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous